Organization | Universidade Federal do Para

Universidade Federal do Para Report issue

Academic/Hospital Phase 1 Phase 3

Founded: Belem Brazil (1957)

Organization Overview

First Clinical Trial

2016

NCT03514290

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

Federal University of Para | Federal University of Pará | Universidade Federal do Para | Universidade Federal do Pará

Active Ingredients

Drugs in Phase 3 Trials (3)

potassium nitrate (2 trials)

pregabalin (lyrica) (1 trial)

sodium fluoride (1 trial)

Drugs in Phase 1 Trials (1)

sodium fluoride (18F) (2 trials)

Drugs in Other Trials (7)

casein phosphopeptide amorphous calcium phosphate (1 trial)

glutaraldehyde (1 trial)

hydrogen peroxide (4 trials)

oxalate (1 trial)

phosphoric acid (Freamine) (1 trial)

propolis (1 trial)

strontium chloride (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Dentin Sensitivity (Phase 1)

Hypersensitivity (Phase 1)

Overview

Highest Phase: Phase 3
# of Trials: 11
# of Trial APIs: 11